Literature DB >> 10974497

Serotonin potentiates the response of neurons of the superficial laminae of the rat spinal dorsal horn to gamma-aminobutyric acid.

H Li1, B Lang, J F Kang, Y Q Li.   

Abstract

Employing the Nystatin-perforated whole-cell patch-clamp recording technique, the modulatory effects of serotonin (5-HT) on gamma-aminobutyric acid (GABA)-activated whole-cell currents were investigated in neurons acutely dissociated from the superficial laminae (laminae I and II) of the rat spinal dorsal horn. The results showed: (1) GABA acted on GABA(A) receptors and elicited inward Cl(-) currents (I(GABA)) at a holding potential (V(H)) of -40 mV; (2) 5-HT potentiated GABA-induced Cl(-) current without affecting the reversal potential of I(GABA) and the apparent affinity of GABA to its receptor; (3) alpha-methyl-5-HT, a selective agonist of 5-HT(2) receptor, mimicked the potentiation effect of 5-HT on I(GABA), whereas ketanserine, an antagonist of 5-HT(2) receptor, blocked the potentiation effect of 5-HT; (4) Chelerythrine, an inhibitor of protein kinase C, reduced the potentiation effect of 5-HT on I(GABA). The present results indicate: (1) The potentiation of 5-HT on I(GABA) is mediated by 5-HT(2) receptor and through a protein kinase-dependent transduction pathway; (2) The interactions between 5-HT and GABA might play an important role in the modulation of nociceptive information transmission at spinal cord level.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10974497     DOI: 10.1016/s0361-9230(00)00297-5

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  9 in total

1.  Disrupting 5-HT(2A) receptor/PDZ protein interactions reduces hyperalgesia and enhances SSRI efficacy in neuropathic pain.

Authors:  Xavier Pichon; Anne S Wattiez; Carine Becamel; Ingrid Ehrlich; Joel Bockaert; Alain Eschalier; Philippe Marin; Christine Courteix
Journal:  Mol Ther       Date:  2010-06-08       Impact factor: 11.454

2.  Serotonin as a modulator of glutamate- and GABA-mediated neurotransmission: implications in physiological functions and in pathology.

Authors:  L Ciranna
Journal:  Curr Neuropharmacol       Date:  2006-04       Impact factor: 7.363

3.  Serotonin and GABA are colocalized in restricted groups of neurons in the larval sea lamprey brain: insights into the early evolution of neurotransmitter colocalization in vertebrates.

Authors:  Antón Barreiro-Iglesias; María Eugenia Cornide-Petronio; Ramón Anadón; María Celina Rodicio
Journal:  J Anat       Date:  2009-06-22       Impact factor: 2.610

Review 4.  Fast synaptic inhibition in spinal sensory processing and pain control.

Authors:  Hanns Ulrich Zeilhofer; Hendrik Wildner; Gonzalo E Yévenes
Journal:  Physiol Rev       Date:  2012-01       Impact factor: 37.312

5.  GABA(A) Receptors: Post-Synaptic Co-Localization and Cross-Talk with Other Receptors.

Authors:  Amulya Nidhi Shrivastava; Antoine Triller; Werner Sieghart
Journal:  Front Cell Neurosci       Date:  2011-06-22       Impact factor: 5.505

Review 6.  Serotonergic Modulation of Nociceptive Circuits in Spinal Cord Dorsal Horn.

Authors:  Rita Bardoni
Journal:  Curr Neuropharmacol       Date:  2019       Impact factor: 7.363

7.  Identification of 5-HT receptor subtypes enhancing inhibitory transmission in the rat spinal dorsal horn in vitro.

Authors:  Du-Jie Xie; Daisuke Uta; Peng-Yu Feng; Masahito Wakita; Min-Chul Shin; Hidemasa Furue; Megumu Yoshimura
Journal:  Mol Pain       Date:  2012-08-20       Impact factor: 3.395

Review 8.  Serotonergic modulation of post-synaptic inhibition and locomotor alternating pattern in the spinal cord.

Authors:  Florian Gackière; Laurent Vinay
Journal:  Front Neural Circuits       Date:  2014-08-28       Impact factor: 3.492

9.  Piroxicam-mediated modulatory action of 5-hydroxytryptamine serves as a "brake" on neuronal excitability in ischemic stroke.

Authors:  Pallab Bhattacharya; Anand Kumar Pandey; Sudip Paul; Ranjana Patnaik
Journal:  Neural Regen Res       Date:  2015-09       Impact factor: 5.135

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.